Nvax stock price edged up to $4

NVAX stock price edged up to $4.71 following reports of expanded vaccine manufacturing capabilities. This expansion is seen as a revenue growth driver, especially if global health demand remains elevated in Find the latest Novavax, Inc. (NVAX) stock discussion in... NVAX also announced that it has entered into ‘material transfer agreements’ with three unnamed pharmaceutical companies during the first quarter of 2025 to explore the utility of its patented Matrix-M in their portfolios. NVAX stock price is currently trading at $4.63, showing resilience compared to other mid-cap biotech names. Momentum traders see a potential upside if moving averages converge positively this week, with RSI levels indicating oversold conditions.